Dennis M Grasela

Preliminary study of two antiviral agents for hepatitis C genotype 1.

Anna Persson, Vinod Rustgi, A. Lok, 2012, The New England journal of medicine.

Model‐Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development

Marc Pfister, Jeffrey D Wetherington, Rajesh Krishna, 2010, Journal of clinical pharmacology.

Model‐Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry

Marc Pfister, Jeffrey D Wetherington, Rajesh Krishna, 2010, Journal of clinical pharmacology.

Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.

Qi Gao, Min Gao, Steven Sheriff, 2017, Journal of medicinal chemistry.

The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection.

Qi Gao, Huabin Sun, Hong Shi, 2014, Journal of medicinal chemistry.